VIA
DYN icon

Virtus Investment Advisers’s Dyne Therapeutics DYN Stock Holding History

Virtus Investment Advisers’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
14,150
+344
+2% +$5.93K 0.07% 309
2025
Q4 		$270K Buy
13,806
+5,937
+75% +$112K 0.07% 292
2025
Q3 		$99.5K Buy
7,869
+1,366
+21% +$15.6K 0.03% 426
2025
Q2 		$61.9K Buy
6,503
+90
+1% +$991 0.02% 437
2025
Q1 		$67.1K Buy
+6,413
New +$91.7K 0.02% 459

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Virtus Investment Advisers's DYN Position: Q1 2026 in Review

Virtus Investment Advisers increased its Dyne Therapeutics (DYN) stake by 2.5% in Q1 2026, buying an estimated $5.93K and bringing the position to 14,150 shares worth $257K. The position accounts for 0.07% of the portfolio, ranked #309.

Virtus Investment Advisers first reported a position in DYN in Q1 2025 and has held it in 5 quarters since. The position peaked at $270K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Virtus Investment Advisers held 14,150 shares of Dyne Therapeutics worth $257K as of Q1 2026.
  • Virtus Investment Advisers bought 344 Dyne Therapeutics shares in Q1 2026, an estimated $5.93K.
  • Dyne Therapeutics made up 0.07% of Virtus Investment Advisers's portfolio in Q1 2026, its #309 holding.
  • Virtus Investment Advisers first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Virtus Investment Advisers's Dyne Therapeutics position peaked at $270K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.